UnitedHealth Group Incorporated $UNH Shares Bought by Members Trust Co

Members Trust Co raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 13.6% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,479 shares of the healthcare conglomerate’s stock after buying an additional 177 shares during the quarter. Members Trust Co’s holdings in UnitedHealth Group were worth $461,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. GAMMA Investing LLC grew its stake in shares of UnitedHealth Group by 7.4% during the 1st quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock worth $8,295,000 after purchasing an additional 1,089 shares during the period. Walkner Condon Financial Advisors LLC grew its stake in shares of UnitedHealth Group by 4.2% during the 1st quarter. Walkner Condon Financial Advisors LLC now owns 890 shares of the healthcare conglomerate’s stock worth $466,000 after purchasing an additional 36 shares during the period. Finally, Foundation Wealth Management LLC PA boosted its position in shares of UnitedHealth Group by 6.9% in the 1st quarter. Foundation Wealth Management LLC PA now owns 1,765 shares of the healthcare conglomerate’s stock worth $925,000 after buying an additional 114 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.3%

Shares of UNH stock opened at $365.47 on Wednesday. The firm has a market cap of $331.00 billion, a P/E ratio of 15.83, a PEG ratio of 2.36 and a beta of 0.47. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm’s 50-day simple moving average is $333.70 and its 200-day simple moving average is $341.28.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Jefferies Financial Group increased their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday, October 17th. KeyCorp increased their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Royal Bank Of Canada decreased their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Finally, Piper Sandler decreased their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.